The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical Hemorheology and Microcirculation

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/CHM-1997-015PMID 9255435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Some marginal notes on erythrocyte aggregation

  2016cited by this paper
• Microrheology and light transmission of blood

  2004cited by this paper
• Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial.

  1996cited by this paper
• Hemorheological effects of poloxamer 188 (rheothrx© injection)

  1995influential reference
• Hemorheological and hemodynamical parameters in patients with ischemic heart disease at rest and at peak exercise

  1994cited by this paper
• Hemorheologic and Coagulative Pattern in Hypercholesterolemic Subjects Treated with Lipid-Lowering Drugs

  1991cited by this paper
• Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies

  1991cited by this paper
• Plasma fibrinogen and ischemic heart disease risk factors.

  1991cited by this paper
• Effects of different thrombolytic agents on blood rheology in acute myocardial infarction

  1991influential reference
• Depletion flocculation and depletion stabilization of erythrocytes

  1990cited by this paper
• Rheological aspects of red blood cell aggregation

  1990cited by this paper
• Increased Whole Blood Viscosity during Coronary Artery Bypass Surgery

  1990cited by this paper
• Plasma fibrinogen — an independent cardiovascular risk factor

  1990cited by this paper
• Pattern recognition in evaluation of haemorheological and haemodynamical measurements in the cardiological diagnostics.

  1990cited by this paper
• The Effect of Poloxamer 188 on the Rate of In Vitro Thrombolysis Mediated by t-PA and Streptokinase

  1990cited by this paper
• Freshwater fish diet affects lipid composition, deformability and aggregation properties of erythrocytes.

  1990cited by this paper
• Modification of acute focal ischemia in rabbits by poloxamer 188.

  1989cited by this paper
• Effects of cellular factors on the aggregation behavior of human, rat and bovine erythrocytes

  1989cited by this paper
• Hemorheological changes during the hospital phase of acute myocardial infarction: sex differences?

  1989influential reference
• Hemorheological abnormalities in chronic renal failure

  1988cited by this paper
• Intrinsic Colloidal Attraction/Repulsion between Lipid Bilayers and Strong Attraction Induced by Non-adsorbing Polymers

  1988cited by this paper
• Erythrocyte aggregation and cardiovascular risk factors

  1988cited by this paper
• 10 The effect of rheothrx™ copolymer and streptokinase on recovery from ischemia in the isolated perfused rat heart

  1988cited by this paper
• Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes.

  1987cited by this paper
• Hemorheology: Importance of erythrocyte aggregation

  1987cited by this paper
• Influence of cellular properties on red cell aggregation

  1987cited by this paper
• Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease.

  1987cited by this paper
• Plasma viscosity and haematocrit in the course of acute myocardial infarction.

  1987influential reference
• Importance of red cell aggregation in venous pathology

  1987cited by this paper
• Hemorheological disturbances during thrombo-embolic states and various attacks

  1987cited by this paper
• Blood rheology in myocardial infarction and hypertension

  1986influential reference
• Hemorrheologic changes following acute myocardial infarction.

  1982cited by this paper
• Observations on blood viscosity changes after acute myocardial infarction.

  1975influential reference

• The Effect of Glucose and Poloxamer 188 on Red-Blood-Cell Aggregation

  2021cites this paper
• Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury

  2019cites this paper
• Improved biocompatibility of polyethylenimine (PEI) as a gene carrier by conjugating urocanic acid: In vitro and in vivo

  2015cites this paper
• The role of hemorheological factors in cardiovascular medicine

  2014cites this paper
• Role Ca(2+) in mechanisms of the red blood cells microrheological changes.

  2012cites this paper
• Changes in Whole Blood Viscosity at Low Shear Rates Correlate with Intravascular Volume Changes during Hemodialysis

  2012cites this paper
• Determinants of Red Blood Cell Aggregation

  2011cites this paper
• Effect of surfactants on the therapeutic efficacy of atovaquone nanosuspensions against acute and reactivated murine toxoplasmosis

  2009cites this paper
• Red blood cell aggregation: 45 years being curious

  2009cites this paper
• EFFECTS OF IMPAIRED GLUCOSE METABOLISM, AGING AND METEOROLOGICAL FACTORS ON HEMORHEOLOGICAL PARAMETERS AND PLATELET AGGREGATION

  2009cites this paper
• Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps

  2007cites this paper
• Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.

  2007cites this paper
• PLATELET AGGREGATION AND VISCOSITY MEASUREMENTS IN THE CLINICAL PRACTICE AND IN BASIC RESEARCH

  2007cites this paper
• Histamine as a Potential Initiator of Sickle Pain crisis by Mediation of Sickle Erythrocyte Adherence in a Shear-Dependent Manner

  2006cites this paper
• Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.

  2006cites this paper
• Fabrication of nanoparticles within polymeric pores for controlled release of drug.

  2006cites this paper
• Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats.

  2004cites this paper
• Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.

  2004cites this paper
• The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation.

  2004cites this paper
• Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers.

  2004cites this paper
• Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation.

  2004cites this paper
• Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier.

  2003cites this paper
• Follow‐up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes

  2003cites this paper
• Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers.

  2002cites this paper
• Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans.

  2002cites this paper
• Long-circulating and target-specific nanoparticles: theory to practice.

  2001cites this paper
• Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.

  2001cites this paper
• The Ability of Poloxamers to Inhibit Platelet Aggregation Depends on their Physicochemical Properties

  2001cites this paper
• Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty

  2001cites this paper
• Aggregation of human RBC in binary dextran–PEG polymer mixtures

  2001cites this paper
• Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods.

  2001cites this paper
• Hemorheological alterations in patients with diabetic retinopathy

  2001cites this paper
• Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

  2000cites this paper
• Inhibition of polymer‐induced red blood cell aggregation by poloxamer 188

  2000cites this paper
• The effect of low‐molecular weight dextran on erythrocyte aggregation in normal and preeclamptic pregnancy

  2000cites this paper
• Effect of transfusion on the endothelium dependent dilatation of brachial artery in patients with chronic anemia

  1999cites this paper
• The non‐ionic surfactant Poloxamer 188 (RheothRx®) increases plasma and whole blood viscosity

  1998cites this paper